0001104659-18-038713.txt : 20180606 0001104659-18-038713.hdr.sgml : 20180606 20180606213326 ACCESSION NUMBER: 0001104659-18-038713 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20180312 FILED AS OF DATE: 20180606 DATE AS OF CHANGE: 20180606 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: MICEK JOHN CENTRAL INDEX KEY: 0001243187 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36714 FILM NUMBER: 18885061 MAIL ADDRESS: STREET 1: 300 HAMILTON AVENUE, 4TH FLOOR CITY: PALO ALTO STATE: CA ZIP: 94301 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Jaguar Health, Inc. CENTRAL INDEX KEY: 0001585608 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 201 MISSION STREET, SUITE 2375 CITY: SAN FRANCISCO STATE: CA ZIP: 94105 BUSINESS PHONE: 415-896-5081 MAIL ADDRESS: STREET 1: 201 MISSION STREET, SUITE 2375 CITY: SAN FRANCISCO STATE: CA ZIP: 94105 FORMER COMPANY: FORMER CONFORMED NAME: Jaguar Animal Health, Inc. DATE OF NAME CHANGE: 20130830 4 1 a4.xml 4 X0306 4 2018-03-12 0 0001585608 Jaguar Health, Inc. JAGX 0001243187 MICEK JOHN C/O JAGUAR HEALTH, INC. 201 MISSION STREET, SUITE 2375 SAN FRANCISCO CA 94105 1 0 0 0 Stock Option (right to buy) 8.40 2018-03-12 4 A 0 38643 0 A 2027-08-02 Common Stock 38643 38643 D Stock Option (right to buy) 2.39 2018-06-01 4 A 0 146804 0 A 2028-05-14 Common Stock 146804 146804 D Granted pursuant to the Issuer's 2014 Equity Incentive Plan All share numbers and the exercise price reflect the 1-for-15 reverse stock split effected on June 1, 2018. The option grant was approved by the Issuer's board of directors on August 2, 2017, subject to shareholder approval of the amendment to the 2014 Stock Incentive Plan. The Issuer's shareholders approved the amendment on March 12, 2018. Vests in equal monthly installments, beginning August 2, 2017, such that it is vested in full on the 3-year anniversary of the grant date. The option grant was approved by the Issuer's board of directors on May 14, 2018, subject to the stockholders approving and effecting a reverse stock split. The Issuer's shareholders approved the reverse stock split on May 18, 2018 and effected such stock split on June 1, 2018. Vests in equal monthly installments, beginning on May 14, 2018, such that it is vested in full on the 3-year anniversary of the grant date. /s/ Karen S. Wright, Attorney-in-Fact 2018-06-06